Denver, CO: The use of CBD is associated with a reduction in post-traumatic stress symptoms in patients diagnosed with the disorder, according to clinical data published in the Journal of Alternative and Complimentary Medicine.
Researchers from the University of Colorado and elsewhere assessed the impact of the adjunctive use of oral CBD over an eight-week period in a cohort of eleven patients with post-traumatic stress.
CBD administration was associated with reduced symptoms in ten of the eleven patients. None of the trial participants discontinued CBD treatment because of adverse side-effects.
“Administration of oral CBD in addition to routine psychiatric care was associated with PTSD symptom reduction in adults with PTSD,” investigators concluded. “CBD also appeared to offer relief in a subset of patients who reported frequent nightmares as a symptom of their PTSD. Additional clinical investigation, including double-blind, placebo-controlled trials, would be necessary to further substantiate the response to CBD that was observed in this study.”
For more information, contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org. Full text of the study, “Cannabidiol in the treatment of post-traumatic stress disorder: A case series,” appears in the Journal of Alternative and Complimentary Medicine. Further information is available from NORML’s fact-sheet, “Marijuana and Veterans Issues.”